| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.032 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |